LOXO-783: A potent, highly mutant selective and brain-penetrant allosteric PI3K alpha H1047R inhibitor in combination with standard of care (SOC) treatments in preclinical PI3K alpha H1047R-mutant breast cancer modelsLoredana Puca, Michele S. Dowless, Carmen M. Perez-Ferreiro, Maria Jesus Ortiz-Ruiz, Gregory P. Donoho, Andrew Capen, Lysiane Huber, Sarah M. Bogner, Dongling Fei,Jason R. Manro, Chun Ping Yu, Wei Guo Xu,Rui Wang,Shuang Chen, Mark A. Hicks, Parisa Zolfaghari, Andrew Faber,Raymond Gilmour, Monica D. Ramstetter,Matthew T. Chang,Maria Jose Lallena,Xuequian Gong,David M. Hyman,Lillian M. Smyth,Barbara J. Brandhuber,Barry S. Taylor,Anke KlippelCANCER RESEARCH（2023）引用 0|浏览18暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
